Sandeep Sahay

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research interests

Pulmonary Hypertension

Pulmonary Arterial Hypertension

Interstitial Lung Diseases

Education/Academic qualification

Critical Care

Award Date: Oct 9 2015

Pulmonary Diseases, MD

Award Date: Oct 9 2015

External positions

Assistant Professor, Weill Cornell Medicine

Dec 1 2016 → …

Research Area Keywords

Clinical Care
Clinical Translation & Trials

Free-text keywords

Pulmonary hypertension
Pulmonary fibrosis
Pulmonary arterial hypertension

Fingerprint

Dive into the research topics where Sandeep Sahay is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Finished
4 Not started
13 Active

An International, Non-Drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy With Guideline-directed Assessments of Disease Severity
Sahay, S. & Safdar, Z.
2/25/22 → …
Project: Clinical Trial
RiOciguAt UseRs Registry The ROAR registry
Sahay, S. & Safdar, Z.
11/30/21 → …
Project: Clinical Trial
Gossamer_GB002-2102_Phase 2 OLE_Pulmonary Arterial Hypertension An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)
Sahay, S. & Safdar, Z.
9/15/21 → …
Project: Clinical Trial
Phase 3_Sotatercept_ Pulmonary Arterial Hypertension _Acceleron A011-12 SOTERIA A Long-term Follow-up Study of Sotatercept for PAH Treatment
Safdar, Z. & Sahay, S.
8/5/21 → …
Project: Clinical Trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH_A011-11 (STELLAR)
Safdar, Z. & Sahay, S.
7/30/21 → …
Project: Clinical Trial

398 Citations
11 h-Index
34 Article
12 Review article
8 Letter
1 Editorial
More
- 1 Short survey

An adult case of NOTCH3 mutation in pulmonary artery hypertension
Padhye, A. A. & Sahay, S., Jan 2022, In: Pulmonary Circulation. 12, 1, e12050.
Research output: Contribution to journal › Article › peer-review

Open Access
E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
Sahay, S., Bhatt, J., Beshay, S., Guha, A., Nguyen, D. T., Graviss, E. A. & Nagueh, S. F., Jan 2022, In: Pulmonary Circulation. 12, 1, e12026.
Research output: Contribution to journal › Article › peer-review

Open Access
Progression of pulmonary veno-occlusive disease without pulmonary hypertension
Beshay, S., Humbert, M., Barrios, R. & Sahay, S., Jan 2022, In: Pulmonary Circulation. 12, 1, e12046.
Research output: Contribution to journal › Article › peer-review

Open Access
Assessment of pinch force strength in patients with pulmonary arterial hypertension in the era of AOS® dry powder inhaler based therapies
Sahay, S., Holy, R., Lyons, S., Parsley, E., Maurer, M. & Weers, J., Feb 2021, In: Respiratory Medicine. 177, 106308.
Research output: Contribution to journal › Article › peer-review
Causes and Circumstances of Death in Portopulmonary Hypertension
Sahay, S., Al Abdi, S., Melillo, C., Newman, J., Dweik, R. A., Heresi, G. A. & Tonelli, A. R., 2021, (Accepted/In press) In: Transplantation Direct. e710.
Research output: Contribution to journal › Article › peer-review

Open Access

Sandeep Sahay, MD, FCCP

Personal profile

Research interests

Education/Academic qualification

External positions

Research Area Keywords

Free-text keywords

Fingerprint

Network

Dive into details

An International, Non-Drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy With Guideline-directed Assessments of Disease Severity

RiOciguAt UseRs Registry The ROAR registry

Gossamer_GB002-2102_Phase 2 OLE_Pulmonary Arterial Hypertension An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

Phase 3_Sotatercept_ Pulmonary Arterial Hypertension _Acceleron A011-12 SOTERIA A Long-term Follow-up Study of Sotatercept for PAH Treatment

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH_A011-11 (STELLAR)

An adult case of NOTCH3 mutation in pulmonary artery hypertension

E-REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension

Progression of pulmonary veno-occlusive disease without pulmonary hypertension

Assessment of pinch force strength in patients with pulmonary arterial hypertension in the era of AOS® dry powder inhaler based therapies

Causes and Circumstances of Death in Portopulmonary Hypertension

Sandeep Sahay, MD, FCCP

Personal profile

Research interests

Education/Academic qualification

External positions

Research Area Keywords

Free-text keywords

Fingerprint

Network

Projects

Research output